<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02668861</url>
  </required_header>
  <id_info>
    <org_study_id>FirstTianjunMU</org_study_id>
    <nct_id>NCT02668861</nct_id>
  </id_info>
  <brief_title>Effect of Oral Vitamin D3 on Chronic Rhinosinusitis Treatment in Adults With Lower Vitamin D Levels</brief_title>
  <official_title>Influence of Oral Vitamin D3 on Wound Healing After Endonasal Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyposis and Lower Vitamin D Levels</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The First Affiliated Hospital of Shanxi Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The First Affiliated Hospital of Shanxi Medical University</source>
  <brief_summary>
    <textblock>
      The purpose of the study is to test the clinical efficacy of oral Vitamin D3 on Wound Healing
      in patients with Chronic Rhinosinusitis With Nasal Polyposis and Lower Vitamin D Levels After
      Endonasal Endoscopic Sinus Surgery
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VAS evaluation of usual symptoms in patients with CRSwNP</measure>
    <time_frame>at 8 weeks after first drug intake</time_frame>
    <description>The evaluated symptoms were nasal obstruction, anterior nasal discharge and post-nasal drip, smelling reduction and facial pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Questionnaire：SNOT-20 evaluates the quality of Life</measure>
    <time_frame>at 8 weeks after first drug intake</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of Lund-Kennedy scores</measure>
    <time_frame>at 8 weeks after first drug intake</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inflammatory mediators in serum</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Histologic analysis of nasal mucosa</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Chronic Rhinosinusitis With Nasal Polyps</condition>
  <arm_group>
    <arm_group_label>Vitamin D+Budesonide Nasal Spray</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin D 4000IU/day for 8 weeks + Budesonide Nasal Spray 128ug/d for 8 week</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo+Budesonide Nasal Spray</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo for 8 weeks + Budesonide Nasal Spray128ug/d for 8 week</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D</intervention_name>
    <description>Vitamin D 4000IU/day for 8 weeks</description>
    <arm_group_label>Vitamin D+Budesonide Nasal Spray</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Budesonide Nasal Spray</intervention_name>
    <description>Budesonide Nasal Spray 128ug/d for 8 week</description>
    <arm_group_label>Vitamin D+Budesonide Nasal Spray</arm_group_label>
    <arm_group_label>placebo+Budesonide Nasal Spray</arm_group_label>
    <other_name>Rhinocort Aqua</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>placebo for 8 weeks</description>
    <arm_group_label>placebo+Budesonide Nasal Spray</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1. Clinical diagnosis of Chronic Rhinosinusitis with nasal polyps 2. Be 18-60 years
             old of Chinese people and of either sex，the Han nationality 3. Vitamin D level of less
             than 30 ng/ml

        Exclusion Criteria:

          -  1. Women must not be pregnant, breast feeding 2. Chronic oral corticosteroid therapy
             3. History of physician-diagnosed nephrolithiasis 4. Chronic diseases（
             diabetes，Hypertension，renal insufficiency, severe liver disease） 5.prior surgeries of
             the paranasal sinuses 6. With an upper respiratory tract infection within 4 weeks of
             entering the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jun Tian</last_name>
    <phone>13603514451</phone>
    <email>zguotian@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ying Y Fang</last_name>
    <phone>15703410761</phone>
    <email>m15703410761@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The First Hospital of Shanxi Medical University</name>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huang F Hui</last_name>
      <phone>13934518228</phone>
      <email>13934518228@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2016</study_first_submitted>
  <study_first_submitted_qc>January 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2016</study_first_posted>
  <last_update_submitted>December 3, 2016</last_update_submitted>
  <last_update_submitted_qc>December 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The First Affiliated Hospital of Shanxi Medical University</investigator_affiliation>
    <investigator_full_name>Jun Tian</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sinusitis</mesh_term>
    <mesh_term>Nasal Polyps</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Budesonide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

